20
Archimica Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is BROENAC SODIUM, with a corresponding US DMF Number 23704.
Remarkably, this DMF maintains an Active status since its submission on April 12, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 31, 2013, and payment made on July 18, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II